
UNEEG medical A/S is a Danish medtech company founded in 2005, specializing in ultra long-term subcutaneous EEG monitoring for epilepsy management. Their flagship product, UNEEG EpiSight, enables continuous, longitudinal EEG recording for months to years, providing objective seizure and sleep data. This data aids in diagnosing challenging cases, tracking seizure burden, and optimizing treatment. The solution comprises a subcutaneous EEG chip (UNEEG SubQ), a discreet wireless recorder, a user-friendly smartphone app, and an AI-powered analytics platform. UNEEG medical aims to improve the quality of life for epilepsy patients by providing more accurate seizure knowledge and insights into the link between epilepsy and sleep. The company has subsidiaries in Germany, the UK, Austria, and the US, and employs approximately 40 people. They have received FDA Breakthrough Device Designation and EU approval for a 3-year continuous use of their implant.

UNEEG medical A/S is a Danish medtech company founded in 2005, specializing in ultra long-term subcutaneous EEG monitoring for epilepsy management. Their flagship product, UNEEG EpiSight, enables continuous, longitudinal EEG recording for months to years, providing objective seizure and sleep data. This data aids in diagnosing challenging cases, tracking seizure burden, and optimizing treatment. The solution comprises a subcutaneous EEG chip (UNEEG SubQ), a discreet wireless recorder, a user-friendly smartphone app, and an AI-powered analytics platform. UNEEG medical aims to improve the quality of life for epilepsy patients by providing more accurate seizure knowledge and insights into the link between epilepsy and sleep. The company has subsidiaries in Germany, the UK, Austria, and the US, and employs approximately 40 people. They have received FDA Breakthrough Device Designation and EU approval for a 3-year continuous use of their implant.
Founded: 2005 (Denmark)
Product: UNEEG EpiSight — subcutaneous ultra long-term EEG system (SubQ implant, recorder, app, AI analytics)
Use case: Continuous months-to-years EEG monitoring for epilepsy diagnosis, seizure burden tracking, and treatment optimization
Regulatory: EU approval for 3-year continuous use of implant
Employees (approx.): About 40–61
Epilepsy diagnosis and management; long-term objective seizure and sleep monitoring.
2005
Medical devices / Medtech
Public profiles list grant-based funding and a disclosed grant round led by SBRI Healthcare.